CITIZENSDX LLC
NPI 1356946164
Clinical Medical Laboratory in Louisville, KY
NPI Status: Active since December 01, 2020
Contact Information
4360 BROWNSBORO RD STE 315
LOUISVILLE, KY
ZIP 40207
Phone: (502) 244-2441
- Organization
- Clinical Medical Laboratory
- CLIA Number: 18D2209823
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 04-27-2027
About CITIZENSDX LLC
This page provides the complete NPI Profile along with additional information for Citizensdx Llc, a provider established in Louisville, Kentucky operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1356946164 assigned on December 2020. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated one year ago. The organization operates as a Single Specialty Group with one or more individual practitioners, all of who practice with the same area of specialization. The authorized official of this NPI record is Joy L Stevens (Vice President Of Revenue Assurance)
- NPI
- 1356946164
- Provider Name
- CITIZENSDX LLC
- Entity Type
- Organization
- Location Address
- 4360 BROWNSBORO RD STE 315 LOUISVILLE, KY 40207
- Location Phone
- (502) 244-2441
- Mailing Address
- 4350 BROWNSBORO RD STE 210 LOUISVILLE, KY 40207
- Mailing Phone
- (502) 244-2441
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 12-01-2020
- Last Update Date
- 11-18-2025
- Code Navigator
Establishments like Citizensdx Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Secondary Taxonomies
The provider has reported to the NPI enumerator additional taxonomy codes. Multiple taxonomy codes may represent subspecialties or other areas of specialization the provider maybe licensed to practice.
| No. | Taxonomy Code | Type | Classification / Specialization |
License No. (State) |
|---|---|---|---|---|
| 1 | 207ZC0006X | Allopathic & Osteopathic Physicians | Pathology |
Group Taxonomy 193400000X SINGLE SPECIALTY GROUP
This provdier is a business group of one or more individual practitioners, all of who practice with the same area of specialization.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Detection of mycoplasma genitalium by dna or rna probe
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique
Detection test by nucleic acid for clostridium difficile, amplified probe technique
Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique
Detection test by nucleic acid for herpes simplex virus, amplified probe technique
Detection test by nucleic acid for human papillomavirus (hpv), high-risk types
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for organism, quantification
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.
This service was performed 34 times for 34 patientsThis test identifies if you have COVID-19, influenza A or B, or respiratory syncytial virus. It uses a multiplex amplified probe technique, which amplifies and detects specific genetic material of the viruses, helping in accurate diagnosis.
This service was performed 1,075 times for 204 patientsThis test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.
This service was performed 727 times for 176 patientsA detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.
This service was performed 539 times for 423 patientsA detection test by nucleic acid for Clostridium difficile using an amplified probe technique is a lab test that identifies the presence of the Clostridium difficile bacteria in your body. It uses a small sample, often stool, and a technique that amplifies the bacteria's genetic material to confirm its presence.
This service was performed 510 times for 434 patientsThis test identifies various pathogens in the digestive system by examining nucleic acids. It targets 6-11 different types or subtypes of these pathogens, helping to diagnose a range of potential illnesses.
This service was performed 15 times for 14 patientsThis test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.
This service was performed 701 times for 173 patientsThis test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.
This service was performed 61 times for 32 patientsThis test detects high-risk types of HPV, a common virus. It's done by analyzing a small sample of cells for the presence of HPV DNA. The aim is to identify any high-risk types early, as they may increase the risk of certain health issues.
This service was performed 34 times for 33 patientsA detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.
This service was performed 696 times for 172 patientsThis is a test that identifies various microorganisms in your body using a method called amplified probe technique. It targets specific genetic material (nucleic acids) of the organisms, amplifying them for easy detection. This helps in diagnosing infections accurately.
This service was performed 816 times for 462 patientsThis is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.
This service was performed 536 times for 420 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 22,053 times for 954 patientsA detection test by nucleic acid quantification is a lab procedure used to identify specific organisms in your body. It measures the amount of an organism's genetic material, helping to diagnose and monitor certain diseases.
This service was performed 1,942 times for 800 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 1,741 times for 967 patientsA detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.
This service was performed 1,025 times for 837 patientsThis test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.
This service was performed 1,024 times for 836 patientsA detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
This service was performed 1,026 times for 833 patientsThis is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.
This service was performed 36 times for 35 patientsThe detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.
This service was performed 1,481 times for 1,145 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 4,744 times for 850 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 956 times for 265 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 1,662 times for 350 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 812 times for 252 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 18D2209823
- Facility Type
- Independent
- Certificate Effective Date
- April 28, 2025
- Certificate Expiration Date
- April 27, 2027
- Laboratory Director
- DR. MAGDALENA OROSZ
- Certificate Type
- Certificate of Compliance
- Certificate Type Description
- This CLIA certificate is issued to Citizensdx Llc after an inspection that finds the laboratory to be in compliance with all applicable CLIA requirements. This type of certificate is issued to laboratories that perform nonwaived (moderate and/or high complexity) testing.
Reviews for CITIZENSDX LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1356946164, we treat the final digit (4) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 56. The final step is to find the difference between that total and the next multiple of ten (60 - 56 = 4).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 56 is 60. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1356946164, enumerated as an "organization" on December 01, 2020.
The provider is located at 4360 BROWNSBORO RD STE 315 LOUISVILLE, KY 40207 and the phone number is (502) 244-2441.
Clinical Medical Laboratory with taxonomy code 291U00000X.